Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 20;5(4):103402.
doi: 10.1016/j.xpro.2024.103402. Epub 2024 Dec 6.

Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assay

Affiliations

Protocol for measuring anti-fentanyl antibodies in mouse serum by enzyme-linked immunosorbent assay

Jacob A Koster et al. STAR Protoc. .

Abstract

Enzyme-linked immunosorbent assay (ELISA) offers an effective, inexpensive, and reliable approach for the analysis of humoral immune responses. Here, we describe a protocol for measuring anti-fentanyl antibodies generated by the immunization of mice with novel opioid vaccine candidates. We describe steps for coating BSA-fentanyl antigen and standard wells. We then detail procedures for preparing buffers and performing assays. This protocol is adaptable for use with either BALB/c or C57BL/6J mice strains and can measure antibody isotypes to elucidate class switching. For complete details on the use and execution of this protocol, please refer to Stone et al.1.

Keywords: antibody; cell biology; immunology.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests D.S., O.L., and D.J.D. are named inventors on vaccine adjuvant patents assigned to Boston Children’s Hospital. O.L. has served as a paid consultant to GlaxoSmithKline (GSK) and HilleVax. D.J.D. is on the scientific advisory board of EdJen BioTech and serves as a consultant with Merck Research Laboratories/Merck Sharp & Dohme Corp (a subsidiary of Merck & Co., Inc.). D.J.D., O.L., and C.N.H. are cofounders and sit as scientific advisors of Ovax, Inc. E.B.N. is a scientific advisor to Ovax, Inc. These commercial or financial relationships are unrelated to the current study. C.N.H. is named as an inventor on a patent for anti-fentanyl vaccine assigned to the University of Houston.

Figures

None
Graphical abstract
Figure 1
Figure 1
IgG2a, IgG2c, and IgA coating template Wells shaded green are reserved for standards (Std) and plate blanks. Wells shaded blue correspond to 2 μg/mL BSA-Fentanyl Conjugate.
Figure 2
Figure 2
Assay optimization curves Total IgG detection antibody was tested against increasing concentrations of BSA-FEN coatings of (A). The 1:500 dilution of IgG detection antibody with the 2 μg/mL coating antigen yielded the strongest correlation (r2 = 0.9953). IgG1 detection antibody was tested against increasing concentrations of BSA-FEN coatings (B). The 1:1000 dilution of IgG1 detection antibody with the 2 μg/mL coating antigen yielded the strongest correlation (r2 = 0.9987). IgG2a was coated directly to the ELISA plate at standard curve concentrations (C). No condition for direct IgG2a detection yielded satisfactory correlation coefficients. IgG2a capture antibody was tested at increasing concentrations with various IgG2a detection antibodies (D). When detecting IgG2a standards through the capture method the 2 μg/mL coating antibody with 1:5000 detection gave the strongest correlation coefficient (r2 = 0.9983). Direct detection of IgG2c standards with an anti-IgG2c detection antibody was optimized at a detection concentration of 1:5000 (r2 = 0.9968) (E). Direct detection of IgA found a detection concentration of 1:1000 yielded the strongest correlation (r2 = 0.9989) (F).
Figure 8
Figure 8
Edging effect occurs when the outer wells of an ELISA have higher absorbance value than wells in the center of the plate or even their replicates This may be caused by contamination of the outer wells or uneven temperature across the plate.
Figure 9
Figure 9
Lack of colorimetric development in any well may be the result of one or more process errors including using the wrong substrate, reagents not added or added in the wrong order, low antibody, or lack of coating
Figure 10
Figure 10
Lack of colorimetric development in sample wells may be the result of low antibody concentrations in tested samples, if antibody presence is expected
Figure 11
Figure 11
High background can have several causes including insufficient washing, too much substrate, insufficient blocking, or incubation times being too long
Figure 3
Figure 3
Graphical representation of the standard curve mathematical model
Figure 4
Figure 4
GraphPad Prism start screen to begin data analysis, related to Quantification and statistical analysis step 2 Select an XY Table with enough Y replicates to match the number used for the samples.
Figure 5
Figure 5
Data entry in XY datafile for ELISA analysis, related to Quantification and statistical analysis step 3 Standard curve concentrations are added to the X column with OD values for the concentration matched by row in Group A column. Unknown values are listed below the standards and sample ID for the unknowns can be listed in the row title square to the far left of the page.
Figure 6
Figure 6
Statistical analysis option window in GraphPad Prism for ELISA analysis, related to Quantification and statistical analysis step 4 To interpolate unknowns from a standard curve, select “Hyperbola (X is concentration)”.
Figure 7
Figure 7
Statistical analysis output from standard curve interpolation, related to step 4s Model statistics can be found under the “Table of Results” tab. Interpolated results for unknowns are listed under “Interpolated X mean values” tab in the order they were entered into the datafile.

References

    1. Stone A.E., Scheuermann S.E., Haile C.N., Cuny G.D., Velasquez M.L., Linhuber J.P., Duddupudi A.L., Vigliaturo J.R., Pravetoni M., Kosten T.A., et al. Fentanyl conjugate vaccine by injected or mucosal delivery with dmLT or LTA1 adjuvants implicates IgA in protection from drug challenge. NPJ Vaccines. 2021;6:69. doi: 10.1038/s41541-021-00329-0. - DOI - PMC - PubMed
    1. United States Drug Enforcement Agency. 2024. Controlled Substances Alphabetical Order. July 2024.https://deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf
    1. Conrad B. ”%CV in ELISA: How to Reduce Them and Why They’re Important.” TechNotes. 2023. 2018. https://www.enzolifesciences.com/science-center/technotes/2018/january/c...

Publication types

LinkOut - more resources